Takeda Partners with Twist Bioscience to Expand Biologics Discovery Capabilities

DNA synthesis

Home » Emerging technologies » DNA synthesis

Twist Bioscience Announces Pricing of Upsized $130.0 Million Public Offering of Common Stock

Emily Leproust

Twist Bioscience Market Cap Up 18% To $1.1B On Settlement Of Legal Dispute With Agilent

Avidea Technologies Utilizes GenScript’s Synthesized Neoantigen Peptides for Novel Personalized Cancer Vaccine

Twist Bioscience Announces Strategic Collaboration With Schrödinger for Drug Discovery

GenScript and Genopis Enter Into Strategic Partnership Agreement for Manufacture Service of GMP Plasmids

Evonetix collaborates with imec to scale-up chip-based technology production for third generation DNA synthesis platform

GenScript Releases Precision Mutant Library Services for Drug Development and Synthetic Biology

SGI-DNA Launches Gibson Assembly® RapidAMP™ Technology for its BioXp™ Gene Builder

DNA Script to Open U.S. Office in South San Francisco to Support Commercialization of the Company’s Industry-Leading Enzymatic Synthesis Technology

Evonetix

Evonetix expands facilities and relocates to central Cambridge, UK